Capital Performance Advisors’s Astera Labs ALAB Stock Holding History

Capital Performance Advisors’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-10	Closed	-$524	–	2791
2024 Q3	$524	Buy	+10	New	+$469	﹤0.01%	2227

Other funds holding ALAB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $199B AUM 37.98% 1-Year Est. Return

Atreides Management Boston, Massachusetts $14.3B AUM 116.01% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Capital Performance Advisors's ALAB Position: Q4 2024 in Review

Capital Performance Advisors sold out of Astera Labs (ALAB) in Q4 2024, closing a stake of 10 shares — an estimated $524 sold.

Capital Performance Advisors first reported a position in ALAB in Q3 2024 and held it in 1 quarter. The position peaked at $524 in Q3 2024. 421 funds tracked by Wall St. Rank hold ALAB as of Q4 2024.

Capital Performance Advisors reported no remaining Astera Labs position as of Q4 2024 after selling out during the quarter.
Capital Performance Advisors sold 10 Astera Labs shares in Q4 2024, an estimated $524.
Capital Performance Advisors first reported a position in Astera Labs in Q3 2024 and held it in 1 quarter.
Capital Performance Advisors's Astera Labs position peaked at $524 in Q3 2024.
421 funds tracked by Wall St. Rank held Astera Labs as of Q4 2024.

Based on Capital Performance Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.